- Report
- February 2024
- 184 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 172 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2023
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 181 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 189 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 73 Pages
Canada
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2023
- 79 Pages
South Korea
From €3340EUR$3,500USD£2,799GBP
- Report
- August 2023
- 173 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2023
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2025
- 85 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- February 2025
- 85 Pages
India
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2024
- 82 Pages
Saudi Arabia
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2023
- 78 Pages
Germany
From €3340EUR$3,500USD£2,799GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more